Opening Remarks & Session 1: Metabolic & Alcohol related liver disease
Track: Jenny Heathcote Hepatology Update - Fall Edition Moderator: Elizabeth Lee, Toronto Session's Learning Objectives: 1. Discuss how to improve risk stratification of NAFLD patients through developing a clinical pathway 2. Examine successes and Challenges identified through implementing the Calgary NAFLD pathway: 5 years of experience 3. Learn about the gap in care for pharmacologic management of alcohol use disorder 4. Summarize the pharmacologic options for the management of alcohol use disorder